Literature DB >> 17007850

A prospective evaluation of uterine abnormalities by saline infusion sonohysterography in 1,009 women with infertility or abnormal uterine bleeding.

Ilan Tur-Kaspa1, Michael Gal, Michael Hartman, Jason Hartman, Alex Hartman.   

Abstract

OBJECTIVE: To evaluate the role of saline infusion sonohysterography (SIS) in the investigation of uterine abnormalities and malformations in patients referred for infertility work-up compared with women with abnormal uterine bleeding (AUB).
DESIGN: Prospective cohort study.
SETTING: Academically oriented private practice. PATIENT(S): One thousand nine consecutive women examined by SIS for infertility work-up (n = 600, infertility group) or AUB investigation (n = 409, AUB group). INTERVENTION(S): SIS. MAIN OUTCOME MEASURE(S): Intracavitary abnormalities and uterine anomalies. RESULT(S): Among the women in the infertility group, 16.2% (n = 97) were found to have intracavitary abnormalities, including polyps (13.0%), submucous fibroids (2.8%), and adhesions (0.3%). Significantly, more patients in the AUB group (39.6%, n = 162) revealed intracavitary abnormalities, including polyps (29.8%), submucous fibroids (9.0%), and adhesions (0.7%). In contrast, significantly more uterine anomalies were found in the infertility group (20%, n = 120) compared with the AUB group (9.5%, n = 39). Arcuate uterus was the most common finding (15% vs. 6.4% of patients, respectively). CONCLUSION(S): An SIS procedure for infertility work-up revealed a substantial percentage of infertile patients with intracavitary abnormalities and uterine anomalies. Because the technique is safe, well tolerated, and feasible in an outpatient setting, SIS should be considered routinely in the early stage of infertility and AUB investigation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17007850     DOI: 10.1016/j.fertnstert.2006.05.044

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  8 in total

Review 1.  Three-dimensional saline infusion sonography compared to two-dimensional saline infusion sonography for the diagnosis of focal intracavitary lesions.

Authors:  Lotte L Nieuwenhuis; Frederik Jr Hermans; A J Marjolein Bij de Vaate; Mariska Mg Leeflang; Hans Am Brölmann; Wouter Jk Hehenkamp; Ben Willem J Mol; T Justin Clark; Judith Af Huirne
Journal:  Cochrane Database Syst Rev       Date:  2017-05-05

2.  Hysterosalpingography versus sonohysterography for intrauterine abnormalities.

Authors:  Uchenna C Acholonu; James Silberzweig; Daniel E Stein; Martin Keltz
Journal:  JSLS       Date:  2011 Oct-Dec       Impact factor: 2.172

3.  Clinical approach for the classification of congenital uterine malformations.

Authors:  Grigoris F Grimbizis; Rudi Campo
Journal:  Gynecol Surg       Date:  2012-03-10

Review 4.  The prevalence of congenital uterine anomalies in unselected and high-risk populations: a systematic review.

Authors:  Y Y Chan; K Jayaprakasan; J Zamora; J G Thornton; N Raine-Fenning; A Coomarasamy
Journal:  Hum Reprod Update       Date:  2011-06-24       Impact factor: 15.610

5.  ROUTINE SALINE INFUSION SONOHYSTEROGRAPHY PRIOR TO ASSISTED CONCEPTION: A REVIEW OF OUR INITIAL EXPERIENCE.

Authors:  G Obajimi; B Ogunkinle
Journal:  Ann Ib Postgrad Med       Date:  2016-12

6.  Role of Saline Infusion Sonohysterography in Infertility Evaluation.

Authors:  Vinita Singh; Byasdev Mishra; Snehil Sinha; Sarita Agrawal; Pushpawati Thakur
Journal:  J Hum Reprod Sci       Date:  2018 Jul-Sep

7.  Uterine and Tubal Abnormalities in Infertile Saudi Arabian Women: A Teaching Hospital Experience.

Authors:  Haifa A Al-Turki; Abid H Gullenpet; Anjum Syed; Hind S Al-Saif; Bander F Aldhafery
Journal:  Saudi J Med Med Sci       Date:  2016-03-09

Review 8.  Uterine Factor Infertility, a Systematic Review.

Authors:  Camille Sallée; François Margueritte; Pierre Marquet; Pascal Piver; Yves Aubard; Vincent Lavoué; Ludivine Dion; Tristan Gauthier
Journal:  J Clin Med       Date:  2022-08-21       Impact factor: 4.964

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.